Immunotherapy for pediatric solid tumors

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Although the cure rates for pediatric and adolescent cancer continue to increase, many solid tumor malignancies continue to have overall worse outcomes when compared to acute lymphoblastic leukemia and lymphomas. This is especially true for metastatic or recurrent solid tumors. Immunotherapy may impact how we treat these tumors. Although the number of immunotherapy clinical trials in pediatric patients has been small compared to adults, the results are promising even in patients with advanced disease and should be explored further. In this chapter we will review the different immunotherapeutic approaches that have and are being evaluated in the pediatric oncology setting.

Original languageEnglish (US)
Title of host publicationCancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
PublisherSpringer Berlin Heidelberg
Pages47-67
Number of pages21
ISBN (Print)9783662464106, 9783662464090
DOIs
StatePublished - Jan 1 2015

Fingerprint

Immunotherapy
Pediatrics
Neoplasms
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Clinical Trials

Keywords

  • Children
  • Immunotherapy
  • Solid tumor

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Kopp, L. M., & Katsanis, E. (2015). Immunotherapy for pediatric solid tumors. In Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (pp. 47-67). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-46410-6_3

Immunotherapy for pediatric solid tumors. / Kopp, Lisa M; Katsanis, Emmanuel.

Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors. Springer Berlin Heidelberg, 2015. p. 47-67.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kopp, LM & Katsanis, E 2015, Immunotherapy for pediatric solid tumors. in Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors. Springer Berlin Heidelberg, pp. 47-67. https://doi.org/10.1007/978-3-662-46410-6_3
Kopp LM, Katsanis E. Immunotherapy for pediatric solid tumors. In Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors. Springer Berlin Heidelberg. 2015. p. 47-67 https://doi.org/10.1007/978-3-662-46410-6_3
Kopp, Lisa M ; Katsanis, Emmanuel. / Immunotherapy for pediatric solid tumors. Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors. Springer Berlin Heidelberg, 2015. pp. 47-67
@inbook{33d3fd5b9b3c49b7a477e9ade9617dd8,
title = "Immunotherapy for pediatric solid tumors",
abstract = "Although the cure rates for pediatric and adolescent cancer continue to increase, many solid tumor malignancies continue to have overall worse outcomes when compared to acute lymphoblastic leukemia and lymphomas. This is especially true for metastatic or recurrent solid tumors. Immunotherapy may impact how we treat these tumors. Although the number of immunotherapy clinical trials in pediatric patients has been small compared to adults, the results are promising even in patients with advanced disease and should be explored further. In this chapter we will review the different immunotherapeutic approaches that have and are being evaluated in the pediatric oncology setting.",
keywords = "Children, Immunotherapy, Solid tumor",
author = "Kopp, {Lisa M} and Emmanuel Katsanis",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-662-46410-6_3",
language = "English (US)",
isbn = "9783662464106",
pages = "47--67",
booktitle = "Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Immunotherapy for pediatric solid tumors

AU - Kopp, Lisa M

AU - Katsanis, Emmanuel

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Although the cure rates for pediatric and adolescent cancer continue to increase, many solid tumor malignancies continue to have overall worse outcomes when compared to acute lymphoblastic leukemia and lymphomas. This is especially true for metastatic or recurrent solid tumors. Immunotherapy may impact how we treat these tumors. Although the number of immunotherapy clinical trials in pediatric patients has been small compared to adults, the results are promising even in patients with advanced disease and should be explored further. In this chapter we will review the different immunotherapeutic approaches that have and are being evaluated in the pediatric oncology setting.

AB - Although the cure rates for pediatric and adolescent cancer continue to increase, many solid tumor malignancies continue to have overall worse outcomes when compared to acute lymphoblastic leukemia and lymphomas. This is especially true for metastatic or recurrent solid tumors. Immunotherapy may impact how we treat these tumors. Although the number of immunotherapy clinical trials in pediatric patients has been small compared to adults, the results are promising even in patients with advanced disease and should be explored further. In this chapter we will review the different immunotherapeutic approaches that have and are being evaluated in the pediatric oncology setting.

KW - Children

KW - Immunotherapy

KW - Solid tumor

UR - http://www.scopus.com/inward/record.url?scp=84943391016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943391016&partnerID=8YFLogxK

U2 - 10.1007/978-3-662-46410-6_3

DO - 10.1007/978-3-662-46410-6_3

M3 - Chapter

SN - 9783662464106

SN - 9783662464090

SP - 47

EP - 67

BT - Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors

PB - Springer Berlin Heidelberg

ER -